Global Cochlear Implants Market 2018-2022

◆タイトル:Global Cochlear Implants Market 2018-2022
◆商品コード:IRTNTR20515
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018
◆ページ数:108
◆資料形式:PDF / 英語
◆納品方法:E
◆調査対象地域:
◆産業分野:Healthcare and Life Sciences
◆販売価格オプション(消費税別)
Single UserUSD3,500 ⇒換算¥364,000見積依頼/購入/質問フォーム
Five UserUSD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
Enterprise LicenseUSD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、""について調査・分析し、エグゼクティブサマリー、市場規模及び予測、市場の課題、市場動向、競争状況等の情報をお届けいたします。

About Cochlear Implants

Cis are electronic medical devices that replace the damaged inner ear. They bypass the damaged hair cells of the inner ear and directly stimulate the auditory nerve. They are used by people who are not benefited by the use of conventional hearing aids and have severe-to-profound hearing loss.

Technavio

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
? Market ecosystem
? Market characteristics
? Market segmentation analysis
PART 05: MARKET SIZING
? Market definition
? Market sizing 2017
? Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
? Bargaining power of buyers
? Bargaining power of suppliers
? Threat of new entrants
? Threat of substitutes
? Threat of rivalry
? Market condition
PART 07: MARKET SEGMENTATION BY FITTING TYPE
? Overview
? Comparison by fitting type
? Unilateral implantation
? Bilateral implantation
? Market opportunity by fitting type
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
? Geographical segmentation
? Regional comparison
? CIs market in Americas
? CIs market in EMEA
? CIs market in APAC
? Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
? Market drivers
? Market challenges
PART 12: MARKET TRENDS
? Emerging technological innovations
? Increasing focus on aesthetic appearance and customization of CIs
? Growing focus on emerging markets
PART 13: VENDOR LANDSCAPE
? Overview
? Landscape disruption
? Competitive landscape
PART 14: VENDOR ANALYSIS
? Vendors covered
? Vendor classification
? Market positioning of vendors
? Cochlear
? MED-EL
? Nurotron Biotechnology
? Sonova
? William Demant
PART 15: APPENDIX
? List of abbreviations

Exhibit 01: Parent market
Exhibit 02: Global audiology devices market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global CIs market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Global CIs market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global CIs market 2017-2022 ($ millions)
Exhibit 09: Global CIs market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Global CIs market: Segmentation by fitting type 2017-2022 (% share)
Exhibit 19: Comparison by fitting type
Exhibit 20: Global unilateral cochlear implantation market 2017-2022 ($ millions)
Exhibit 21: Global unilateral cochlear implantation market: Year-over-year growth 2018-2022 (%)
Exhibit 22: Global bilateral cochlear implantation market 2017-2022 ($ millions)
Exhibit 23: Global bilateral cochlear implantation market: Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by fitting type
Exhibit 25: Customer landscape
Exhibit 26: Global CIs market: Segmentation by geography 2017-2022 (% share)
Exhibit 27: Regional comparison
Exhibit 28: CIs market in Americas 2017-2022 ($ millions)
Exhibit 29: CIs market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 30: Top three countries in Americas
Exhibit 31: CIs market in EMEA 2017-2022 ($ millions)
Exhibit 32: CIs market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in EMEA
Exhibit 34: CIs market in APAC 2017-2022 ($ millions)
Exhibit 35: CIs market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Cochlear: Overview
Exhibit 44: Cochlear: Business segments
Exhibit 45: Cochlear: Organizational developments
Exhibit 46: Cochlear: Geographic focus
Exhibit 47: Cochlear: Segment focus
Exhibit 48: Cochlear: Key offerings
Exhibit 49: Cochlear: Key customers
Exhibit 50: MED-EL: Overview
Exhibit 51: MED-EL: Product segments
Exhibit 52: MED-EL: Organizational developments
Exhibit 53: MED-EL: Geographic focus
Exhibit 54: MED-EL: Segment focus
Exhibit 55: MED-EL: Key offerings
Exhibit 56: MED-EL: Key customers
Exhibit 57: Nurotron Biotechnology: Overview
Exhibit 58: Nurotron Biotechnology: Product segments
Exhibit 59: Nurotron Biotechnology: Organizational developments
Exhibit 60: Nurotron Biotechnology: Geographic focus
Exhibit 61: Nurotron Biotechnology: Segment focus
Exhibit 62: Nurotron Biotechnology: Key offerings
Exhibit 63: Nurotron Biotechnology: Key customers
Exhibit 64: Sonova: Overview
Exhibit 65: Sonova: Business segments
Exhibit 66: Sonova: Organizational developments
Exhibit 67: Sonova: Geographic focus
Exhibit 68: Sonova: Segment focus
Exhibit 69: Sonova: Key offerings
Exhibit 70: Sonova: Key customers
Exhibit 71: William Demant: Overview
Exhibit 72: William Demant: Business segments
Exhibit 73: William Demant: Organizational developments
Exhibit 74: William Demant: Geographic focus
Exhibit 75: William Demant: Segment focus
Exhibit 76: William Demant: Key offerings
Exhibit 77: William Demant: Key customers



【掲載企業】

Cochlear, MED-EL, Nurotron Biotechnology, Sonova, and William Demant.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆